Cargando…
An evidence-based review of unoprostone isopropyl ophthalmic solution 0.15% for glaucoma: place in therapy
Glaucoma is a progressive, neurodegenerative optic nerve disease that can cause significant visual morbidity and affects over 60 million people worldwide. The only known modifiable risk factor for glaucoma at this time is elevated intraocular pressure (IOP), which may be treated with medications, la...
Autores principales: | Fung, Derrick S, Whitson, Jess T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958522/ https://www.ncbi.nlm.nih.gov/pubmed/24648719 http://dx.doi.org/10.2147/OPTH.S41562 |
Ejemplares similares
-
Vasodilatory mechanisms of unoprostone isopropyl in isolated porcine retinal arterioles
por: Tanano, Ichiro, et al.
Publicado: (2015) -
Effects of brimonidine tartrate 0.2 and 0.15% ophthalmic solution on the static and dynamic pupil characteristics
por: Yang, Jing, et al.
Publicado: (2023) -
Topical Isopropyl Unoprostone for Retinitis Pigmentosa: Microperimetric Results of the Phase 2 Clinical Study
por: Yamamoto, Shuichi, et al.
Publicado: (2012) -
Erratum to: Topical Isopropyl Unoprostone for Retinitis Pigmentosa: Microperimetric Results of the Phase 2 Clinical Study
por: Yamamoto, Shuichi, et al.
Publicado: (2013) -
Improvement of central retinal sensitivity six months after topical isopropyl unoprostone in patients with retinitis pigmentosa
por: Tawada, Ayako, et al.
Publicado: (2013)